Whitney brings over 25 years of medical technology leadership experience to her new role overseeing strategy and operations across the company’s dental portfolio.
Young Innovations has appointed Rebecca Whitney as chief executive officer, effective July 1, 2026. In this role, Whitney will direct the company’s executive team, managing strategy, operations, and growth initiatives across its portfolio of dental supply and equipment brands.
Medical Technology Leadership Background
Whitney joins the company with more than 25 years of leadership experience in the medical technology sector. She has spent over a decade in spine and orthopedics, holding senior leadership positions at BD Medical, Covidien, GE Healthcare, Zimmer Biomet, and ZimVie. Prior to joining Young Innovations, she served as chief executive officer of Highridge Medical.
“Rebecca is a dynamic and proven leader with a strong track record of driving growth, advancing innovation, and building exceptional teams,” says David Butler, chairman of the board for Young Innovations, in a release. “Her experience scaling organizations, integrating acquisitions, and partnering with clinicians to bring meaningful solutions to market makes her the ideal choice to lead Young into its next chapter.”
Focus on Growth and Partnerships
According to the company, throughout her career, Whitney has managed organic and acquisition-driven growth, collaborated with key opinion leaders on new technologies, and worked across direct and independent distributor channels.
“I look forward to working closely with employees, customers, and partners to build on this momentum and deliver innovative solutions that improve patient outcomes,” says Whitney in a release.
Whitney holds a bachelor’s degree in organizational communication and an MBA from the University of Utah. She is based in Denver.
Photo: Young Innovations
